edoc

Electrophysiology Testing to Stratify Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation

Knecht, Sven and Schaer, Beat and Reichlin, Tobias and Spies, Florian and Madaffari, Antonio and Vischer, Annina and Fahrni, Gregor and Jeger, Raban and Kaiser, Christoph and Osswald, Stefan and Sticherling, Christian and Kühne, Michael. (2020) Electrophysiology Testing to Stratify Patients With Left Bundle Branch Block After Transcatheter Aortic Valve Implantation. Journal of the American Heart Association Cardiovascular and Cerebrovascular Disease, 9 (5). e014446.

[img] PDF - Published Version
Available under License CC BY-NC-ND (Attribution-NonCommercial-NoDerivatives).

338Kb

Official URL: https://edoc.unibas.ch/86460/

Downloads: Statistics Overview

Abstract

Background Left bundle branch block (LBBB) is common after transcatheter aortic valve implantation (TAVI) and is an indicator of subsequent high-grade atrioventricular block (HAVB). No standardized protocol is available to identify LBBB patients at risk for HAVB. The aim of the current study was to evaluate the safety and efficacy of an electrophysiology study tailored strategy in patients with LBBB after TAVI. Methods and Results We prospectively analyzed consecutive patients with LBBB after TAVI. An electrophysiology study was performed to measure the HV-interval the day following TAVI. In patients with normal His-ventricular (HV)-interval ≤55 ms, a loop recorder was implanted (ILR-group), whereas pacemaker implantation was performed in patients with prolonged HV-interval >55 ms (PM-group). The primary end point was occurrence of HAVB during a follow-up of 12 months. Secondary end points were symptoms, hospitalizations, adverse events because of device implantation or electrophysiology study, and death. Of 373 patients screened after TAVI, 56 patients (82±6 years, 41% male) with LBBB were included. HAVB occurred in 4 of 41 patients (10%) in the ILR-group and in 8 of 15 patients (53%) in the PM-group (; P; 55 ms is a feasible and safe approach to stratify patients with regard to developing HAVB during a follow-up of 12 months.
Faculties and Departments:03 Faculty of Medicine > Bereich Medizinische Fächer (Klinik) > Kardiologie > Klinische Outcomeforschung Kardiologie (Müller)
03 Faculty of Medicine > Departement Klinische Forschung > Bereich Medizinische Fächer (Klinik) > Kardiologie > Klinische Outcomeforschung Kardiologie (Müller)
UniBasel Contributors:Knecht, Sven and Jeger, Raban and Schär, Beat and Reichlin, Tobias and Madaffari, Antonio and Vischer, Annina Salome and Fahrni, Gregor and Kaiser, Christoph A. and Osswald, Stefan and Sticherling, Christian and Kühne, Michael
Item Type:Article, refereed
Article Subtype:Research Article
Publisher:American Heart Association
e-ISSN:2047-9980
Note:Publication type according to Uni Basel Research Database: Journal article
Language:English
Identification Number:
edoc DOI:
Last Modified:16 Mar 2022 15:23
Deposited On:16 Mar 2022 15:23

Repository Staff Only: item control page